Queen Mary University of London

University / College


Location: London, United Kingdom (GB) GB

ISNI: 0000000121711133

ROR: https://ror.org/026zzn846

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

EndoCompass project: Research roadmap for pituitary and neuroendocrine tumor endocrinology (2025) Castano JP, Dattani MT, Grozinsky-Glasberg S, Karavitaki N, Pavel ME, Andoniadou C, Alexandraki K, et al. Journal article, Review article A core outcome set for pituitary surgery research: an international delphi consensus study (2025) Valetopoulou A, Newall N, Khan DZ, Borg A, Bouloux PM, Bremner F, Buchfelder M, et al. Journal article Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statement (2025) Newall N, Valetopoulou A, Khan DZ, Borg A, Bouloux PM, Bremner F, Buchfelder M, et al. Journal article Correlation between domain structure dynamics and electromechanical behavior in Sn-doped BaTiO3 (2025) Kraft V, Cicconi MR, Pal S, Kuhfuß M, Khansur NH, Martin A, Kimura K, et al. Journal article Electrospun porous phosphate-based glass fibres containing gallium and clove oil: Cytotoxicity and antioxidant properties (2025) Moghaddam Z, Nery ET, Ünalan I, Hoxha A, Felipe-Sotelo M, Zhao H, Pinna A, et al. Journal article Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial (2025) Powles T, Tagawa S, Vulsteke C, Gross-Goupil M, Park SH, Necchi A, De Santis M, et al. Journal article Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial (2025) Cardoso F, O’Shaughnessy J, Liu Z, McArthur H, Schmid P, Cortes J, Harbeck N, et al. Journal article A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study (2024) Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, et al. Journal article A bitter anti-inflammatory drug binds at two distinct sites of a human bitter taste GPCR (2024) Peri L, Matzov D, Huxley DR, Rainish A, Fierro F, Sapir L, Pfeiffer T, et al. Journal article Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (2024) Schmid P, Cortes J, Dent R, Mcarthur H, Pusztai L, Kümmel S, Denkert C, et al. Journal article